This Blog is also available as an
RSS Feed
The Role of a Greensheet in IPO Investing
9 November 2009 - News - EditorJust as in any type of trading on the stock market, investing in Initial Public Offerings is not without risks. Weighing the pros and cons of an IPO investment can be greatly assisted by checking out the S-1 form lodged with the Securities and Exchange Commission as a requirement for going public. By doing this investors not only get a good idea of the future prospects of the company, but also of what would be a fair price to pay for the stock.
Another valuable tool for IPO investing is the company's greensheet – an informative document summarizing the main components of the prospectus of a new issue. This document, which is prepared by an underwriter and lists the advantages and disadvantages of a new issue, is not available to the general public, being created with the purpose of assisting brokers and the underwriter's sales team in their quest to market the IPO. The greensheet also assists brokers and salespeople who are familiar with their customer base to narrow down who they aim to approach first with an IPO offer. This often results in the big-money investors snapping up the worthwhile deals first.
Although legally a greensheet should not contain any information that is not available in the company's prospectus, bearing in mind that this is a document intended for internal use, it is likely to contain a comparison of the IPO to other stock market listed companies. To cover themselves should the document fall into the hands of someone not employed by the underwriting firm, a disclosure statement will appear on the greensheet, detailing the purpose of the document, including the distribution restrictions and limitations on its information.
While the SEC S-1 form and the greensheet will give a potential stock market investor a reasonable idea of how the company making the IPO stands financially, and even what its future prospects are, it is essential to read the company prospectus which is filed with the SEC. The prospectus will include details on the company's risks and opportunities, as well as what the money raised by the IPO will be used for. If it is to be used to pay outstanding debt, there would be a need for extra caution, but if it is for projects such as expanding into new markets, or research on new products, it may be worth considering.
- Video: Sanofi Board May Support Genzyme Bid; Visa May Face Suit: Video
- Thursday 29 July 2010, 12:17 pm - Video: Hambrecht Says BASF to Outpace Global Chemical Industry
- Thursday 29 July 2010, 10:48 am - Video: Spain's Catalonia Bans Bullfighting After Popular Outcry: Video
- Thursday 29 July 2010, 10:17 am - Video: Brennan Says AstraZeneca to Mull More Buybacks in 2011
- Thursday 29 July 2010, 10:12 am - Video: Lagarde Sees 'Serious Pickup' for Global Growth in 2011
- Thursday 29 July 2010, 10:08 am - Video: Pelham Smithers Says Sony Yet to Hit Earnings Potential
- Thursday 29 July 2010, 9:10 am
- Farnborough International Airshow Points to Aviation Industry Recovery
- Monday 26 July 2010 - Features - Uncertain Economic Outlook Depresses Market
- Thursday 22 July 2010 - Markets - Q2 Results Dominate the Week Ahead
- Monday 19 July 2010 - News - Fed Adopts Cautious Outlook on Pace of Economic Recovery
- Thursday 15 July 2010 - News - Wall Street Focus on Second Quarter Results
- Monday 12 July 2010 - News - IMF Aims to Restore Financial Market Confidence
- Thursday 8 July 2010 - News

User Comments & Reviews
Leave a comment: